AI assistant
Bolt Biotherapeutics, Inc. — Director's Dealing 2021
Feb 5, 2021
35210_dirs_2021-02-04_29ad20fe-98aa-438b-97da-0e586b28d7b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-02-04
Reporting Person: Perez Edith A. (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.80 | 2030-07-28 | Common Stock (225000) | Direct | |
| Stock Option (Right to Buy) | $4.34 | 2030-09-02 | Common Stock (12142) | Direct | |
| Stock Option (Right to Buy) | $4.34 | 2030-09-02 | Common Stock (45000) | Direct |
Footnotes
F1: 1/4th of the shares subject to the option shall vest on the one year anniversary of April 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider through each such date.
F2: This option is immediately exercisable and vests over a four-year period with 1,770 shares vesting on April 3, 2021 and the remainder vesting monthly over 41 months from April 3, 2021.
F3: This option is immediately exercisable and vests over a four-year period with 2,812 shares vesting on April 15, 2021 and the remainder vesting monthly over 45 months from April 15, 2021.